The global biotechnology and pharmaceutical engineering sector is witnessing a significant infrastructural expansion as ABEC prepares to officially open its…
Read More
Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy
In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…
Read More
Biotech Competition Spurs New Secretive Tactics and Shifts Investor Approach
The global biotechnology sector is undergoing a profound cultural and strategic transformation, driven by an increasingly cutthroat competitive landscape that…
Read More
ERS 2026 Insights: Body Mass Index and Type 2 Inflammation as Major Predictors of Asthma Attack Risk
Respiratory medicine continues to evolve as researchers uncover complex interactions between metabolic health, systemic inflammation, and chronic airway diseases. Among…
Read More
UK Health Watchdog Drafts Against Routine NHS Funding for Gilead’s Twice-Yearly HIV Prevention Injection Lenacapavir
The National Institute for Health and Care Excellence (NICE) has issued a preliminary recommendation against the routine NHS commissioning of…
Read More
HHS Appoints Four Permanent Senior Leaders to Stabilize and Reform the US Food and Drug Administration Amid Leadership Turmoil
The US Department of Health and Human Services (HHS) has announced the appointment of four permanent senior leaders to critical…
Read More
Bayer Secures FDA Accelerated Approval for Hyrnuo in Frontline HER2-Mutant Non-Small Cell Lung Cancer
Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…
Read More
Pharma commercial vendor selection still runs on word of mouth: A Harvard MBA student aims to change that with Rx Almanac.
For pharmaceutical companies navigating the complex transition from clinical research to commercial launch, the selection of service providers—ranging from distribution…
Read More
ESC and ERS Congress Review: Breakthrough Data in Cardiology and Pulmonology Highlight Conference Season
The pharmaceutical and clinical research sectors have officially entered peak conference season, marked by high-profile readouts, regulatory milestones, and shifting…
Read More
Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline
Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…
Read More
